A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program.

MLA

Allocco, Dominic J., et al. “A Prospective Evaluation of the Safety and Efficacy of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of de Novo Coronary Artery Lesions: Design and Statistical Methods of the PERSEUS Clinical Program.” Trials, vol. 11, Jan. 2010, p. 1. EBSCOhost, https://doi.org/10.1186/1745-6215-11-1.

APA

Allocco, D. J., Cannon, L. A., Britt, A., Heil, J. E., Nersesov, A., Wehrenberg, S., Dawkins, K. D., & Kereiakes, D. J. (2010). A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program. Trials, 11, 1. https://doi.org/10.1186/1745-6215-11-1

Chicago

Allocco, Dominic J, Louis A Cannon, Amy Britt, John E Heil, Andrey Nersesov, Scott Wehrenberg, Keith D Dawkins, and Dean J Kereiakes. 2010. “A Prospective Evaluation of the Safety and Efficacy of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of de Novo Coronary Artery Lesions: Design and Statistical Methods of the PERSEUS Clinical Program.” Trials 11 (January): 1. doi:10.1186/1745-6215-11-1.